Cholestatic liver dysfunction [8]

Lancet

Volumn 354, Issue 9182, 1999, Pages 954-

  Wierzbicki, A S ^a   Crook, M A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; FENOFIBRATE; FLUINDOSTATIN; PRAVASTATIN; SIMVASTATIN; STATIN;

ACUTE HEPATITIS; ADULT; CASE REPORT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INTRAHEPATIC CHOLESTASIS; LETTER; LIVER FUNCTION TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0033546901     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)75706-8     Document Type: Letter

References (5)

1. A Nakad L Bataille V Hamoir C Sempoux Y Horsman Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin Lancet 353 1999 1763 1764
2. M Ballare M Xampanini G Airoldi Hepatotoxicity of hydroxy-methylglutaryl-coenzyme A reductase inhibitors Minerva Gastroenterol Dietol 38 1992 41 44
3. AS Wierzbicki PJ Lumb YK Semra G Chik ER Christ MA Crook Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias Q J Med 92 1999 387 394
4. AS Wierzbicki TM Reynolds MA Crook J Tatler BS Peters Lipid lowering therapy in patients with HIV infection Lancet 352 1998 1782
5. M Hartleb G Rymarczyk K Januszewski Acute cholestatic hepatitis associated with pravastatin Am J Gastroenterol 94 1999 1388 1390